Skip to main content
. 2020 Dec 29;104(2):519–525. doi: 10.4269/ajtmh.20-1269

Table 3.

Comparison of participant’s responses about management of menstrual disorders/gynecological infection before and during the COVID-19 pandemic

Six months before COVID-19 (control), % (n) During total curfew, % (n) P-value After total curfew, % (n) P-value
Never been treated 21.0 (42) 29.0 (58) 0.068 24.5 (49) 0.464
Phone consultation 8.5 (17) 17.5 (35) 0.01 8.0 (16) 0.865
Going personally to pharmacy for treatment 12.5 (25) 10.0 (20) 0.5 10.0 (20) 0.542
Going personally to clinics for treatment 23.0 (46) 5.5 (11) 0.000 22.0 (44) 1.00
Others 5.5 (11) 6.5 (13) 0.832 5.5 (11) 1.00